Where does Personal Genomics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Personal Genomics, Inc. ranks #20,231 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Personal Genomics, Inc. hold?

Personal Genomics, Inc. holds 14 US utility patents granted between 2015 and 2022, spanning 11 technology areas.

What is Personal Genomics, Inc.'s Innovation Score?

Personal Genomics, Inc. has an Innovation Score of 30.2 out of 100 (top 67% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Personal Genomics, Inc.'s patent grant rate increasing or decreasing?

Personal Genomics, Inc.'s recent grant velocity is -44% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Personal Genomics, Inc.'s patents?

Personal Genomics, Inc.'s patents average 13.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Personal Genomics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Personal Genomics, Inc.

Q: What technology areas does Personal Genomics, Inc. focus on?

Personal Genomics, Inc.'s top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 8 patents. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 14 granted patents across 11 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Personal ranks #20,231 of 50,000 tracked US assignees by granted-patent volume, with 14 patents across 11 technology areas.

#20,231
of 50,000 US assignees by volume: Top 67%
by Innovation Score (30.2/100): 13.3
avg claims per patent: -44%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20231 · Foreign Corporation #20,231 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #20,231/50,000
PHOTO-FINISH PENN ELCOM
CPC-FOCUS G01N · 11 areas
INNOV-THIN 30.2/100
CLAIMS-RICH 13.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -44% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: PENN Elcom Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Personal Genomics · this assignee

30
3D Lighting Innovati… · lowest

7

What this shows Personal Genomics, Inc. stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-THIN, CLAIMS-RICH, TYPE-FRNCORP, VEL-DROP, BOOK-FULL. Volume places it #20,231 of 50,000; Innovation Score 30.2/100 sits in the top 67% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is PENN Elcom Ltd. (±0 grants).

Portfolio overview

Personal Genomics, Inc. has been granted 14 US utility patents between 2015 and 2022, placing Personal Genomics, Inc. at #20,231 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.3 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Personal Genomics, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Personal sits between PENN Elcom Ltd. (14 patents, rank #20,219) and Pharmathen S.a. (14 patents, rank #20,227) - the closest US assignees by grant volume. The composite Innovation Score of 30.2/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 5 grants, compared with 9 in the 2015–2019 window, a -44% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Personal Genomics, Inc.'s 13.3 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 11 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

PENN Elcom

14
Pepex Biomedical

14
Perfect Mobile

14
Performance LAB

14
Petuum

14
Pfannenberg

14
Phadia AB

14
Pharmathen

14
Personal Genomics ◀

14

What this shows Personal holds 14 patents at rank #20,223, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Personal

By rank, the assignees closest to #20,223 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Personal's primary technology class.

Personal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 Top 67% higher than 33% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Personal Genomics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	7.1%
2017	3	21.4%
2018	3	21.4%
2019	2	14.3%
2020	4	28.6%
2022	1	7.1%

Which technologies does Personal Genomics, Inc. patent most?

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 8

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 6

H10F - INORGANIC SEMICONDUCTOR DEVICES SENSITIVE TO INFRARED RADIATION, LIGHT, ELECTROMAGNETIC RADIATION OF SHORTER WAVELENGTH OR CORPUSCULAR RADIATION 6

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 3

B82Y - SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES 2

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 2

Y02E - REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION 1

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 1

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 1

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 1

Top 11 of 11 technology areas

Where it ranks

Overall rank by patents

#20,231

of 50,000 tracked assignees

Innovation Score

30.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.